期刊文献+

HBsAg检测阴性而HBV-DNA检测阳性标本乙肝两对半结果模式分析 被引量:10

下载PDF
导出
摘要 目的对ELISA检测HBsAg结果阴性而HBV-DNA检测阳性标本乙肝两对半结果进行比较分析。方法采用2种不同厂家ELISA试剂对52224例无偿献血者血液标本进行HBsAg检测,核酸检测方法对51797例HBsAg检测阴性标本进行HBV-DNA定性检测,83例HBV-DNA定性检测阳性标本进行HBV-DNA定量检测和乙肝两对半检测。结果 52224例献血者HBsAg检测阴性为51797例;51797例检测HBsAg阴性标本而HBV-DNA定性检测阳性共83例;83例HBVDNA定性检测阳性标本经定量检测53例为阳性;83例HBV-DNA定性检测阳性标本乙肝两对半检测有10种模式,HBcAb阳性占87.95%;HBcAb和HBeAb同时阳性占56.63%;HBsAg阳性占22.89%。结论由于经济原因核酸检测暂不适宜全面推广情况下,为减少经输血传播乙肝,选择灵敏度和特异性好的ELISA试剂检测HBsAg;体检征询发现献血者HBcAb、HBeAb同时阳性时暂缓献血。
机构地区 江西省血液中心
出处 《实验与检验医学》 CAS 2013年第5期496-497,共2页 Experimental and Laboratory Medicine
关键词 HBsAg HBV-DNA 两对半
  • 相关文献

参考文献5

  • 1Kleinman SH,Kuhns MC,Todd DS, et al. Frequency Of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donol" screeuing[J].Transfusion,2003,43(6): 696-704.
  • 2Jarvis L,Becker J,Tender A, et al. Evaluation of the Roche cobas s201 system and cobas TaqScreen multiplex test for blood screen- ing:a European multicenter study[J]. Transfusion, 2008,48(9): 1853- 1861.
  • 3Mine H,Emura H,Miyamoto M, et al. High throughput screening of 16 million serologically negative bloods donors for hepatitis B virus,and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan[Jl.J Virol Methods,2003,112(1-2):145-151.
  • 4岳化葵.酶联免疫吸附法与定量聚合酶链反应对乙肝两对半测定的比较分析[J].临床和实验医学杂志,2008,7(11):73-73. 被引量:8
  • 5王良华,叶贤林,尚桂芳,周雄伟,周晓露.免疫筛查阴性献血者血样病毒核酸检测的研究[J].中国输血杂志,2005,18(4):286-289. 被引量:75

二级参考文献13

  • 1Ganarda JL, Dragon E. Blood screening by nucleic acid amplification technology: current issues, future challenges. Mol Diag,2000,5(1) :11.
  • 2Busch MP, Kleinman SH, Jackson B, et al. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases. Transfusion, 2000,40(2) : 143.
  • 3Busch MP. HIV, HBV, HCV: new developments related to transfusion safety. Vox Sang, 2000,78(Suppl. 2) :253.
  • 4Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis antigen in patients with chronic hepatitis. Lancet, 1989,334:588.
  • 5Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induce escape mutant of hepatitis B virus. Lancet, 1990,336,325.
  • 6Zuckerman AJ, Harrison TJ, Oon CJ. Mutants in the S region of hepatitis B virus. Lancet, 1994,343:737.
  • 7Cacciola I, Pollicino T, Squadrito G, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med,1999, 341(1):22.
  • 8Dow BC, Peterkin MA, Green RH, et al. Hepattis B virus transmission by blood donation negative for hetitis B surface antigen, antibody to HBsAg, antibody to hepatitis B core antigen and HBV DNA. Vox Sang,2001,81(3):140.
  • 9孙南雄,黄祖瑚,刘雁雁,韩亚萍,刘婷,张永祥.乙型肝炎患者957例血清学标志分析[J].中华医学检验杂志,1999,22(5):296-298. 被引量:167
  • 10陆志檬,韩永年.进一步控制经输血传播的病毒感染[J].中华检验医学杂志,2001,24(3):135-136. 被引量:18

共引文献81

同被引文献82

  • 1Velati C.Occult B hepatitis-still a risk for transfusions[J]. ISBT sci- ence series,20 I0,5( I ):73-76.
  • 2Zhang R, Wang L, Li J.Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen [J].Transfusion Med,2010,20(5): 322-328.
  • 3Liu Y, Li P, Li C. Detection of hepatitis B virus DNA among ac- cepted blood donors in Nanjing, China[J]. Virol J,2010,7:193-198.
  • 4Stramer SL, Wend U, Candotti D,et al. Nucleic acid testing to detect HBV infection in blood donors [J]. The new england journal of medicine, 2011, 364(3):236-247.
  • 5Ren FR, Wang JX, Huang Y, et al. Hepatitis B virus nucleic acid tesiing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion, 2011, 51(12):2588-25951.
  • 6Zou S, Stramer SL, Notari EP, et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion, 2009; 49(8):1609-1620.
  • 7Mine H, Emura H, Miyamoto M, et al. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type - 1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods, 2003, 112(1-2): 145- 151.
  • 8Tran TY,Tfinh TN,Abe K.New complex recombinant genotype of hepatitis B virus identified in Vietnam.J Virol 2008,82:5657-5663.
  • 9Tatematsu K, Tanaka Y, Kurbanov F,et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new enotype J. J Virol 2009,83:10538-10547.
  • 10翁厚光.血清标志物与HBVDNA含量的关系及临床检测意义[J].当代医学,2007,14(12):54-55.

引证文献10

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部